Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882

Watchlist Manager
Guangzhou Kingmed Diagnostics Group Co Ltd Logo
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Watchlist
Price: 28.72 CNY 0.67% Market Closed
Market Cap: 13.3B CNY

Guangzhou Kingmed Diagnostics Group Co Ltd
Current Portion of Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Guangzhou Kingmed Diagnostics Group Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Current Portion of Long-Term Debt
ÂĄ209m
CAGR 3-Years
0%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Jinxin Fertility Group Ltd
HKEX:1951
Current Portion of Long-Term Debt
ÂĄ1.4B
CAGR 3-Years
143%
CAGR 5-Years
118%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Current Portion of Long-Term Debt
ÂĄ290m
CAGR 3-Years
28%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Current Portion of Long-Term Debt
ÂĄ80m
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Dian Diagnostics Group Co Ltd
SZSE:300244
Current Portion of Long-Term Debt
ÂĄ881.7m
CAGR 3-Years
16%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Current Portion of Long-Term Debt
ÂĄ1.2B
CAGR 3-Years
-7%
CAGR 5-Years
-12%
CAGR 10-Years
37%
No Stocks Found

Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View

Market Cap
13.3B CNY
Industry
Health Care

Guangzhou Kingmed Diagnostics Group Co Ltd has crafted its journey in the healthcare industry with precision and analytical prowess. Emerging in the early 2000s, Kingmed Diagnostics tapped into a burgeoning market niche—offering diagnostic testing services to hospitals, clinics, and other medical institutions. With a blend of advanced technology and extensive scientific expertise, the company provides a range of services, from routine clinical testing to esoteric evaluations that require more sophisticated techniques. Kingmed’s laboratories, strategically established across China, facilitate a seamless operation that processes millions of tests annually, ensuring timely and accurate results. This operational efficiency not only supports healthcare providers in delivering informed patient care but also positions Kingmed at the forefront of diagnostic innovation. Revenue streams flow through service contracts with healthcare facilities and direct partnerships where they provide specialized testing offerings that institutions may not have the infrastructure to perform in-house. By leveraging economies of scale, Kingmed achieves cost efficiencies, which in turn afford competitive pricing structures, further securing its market position. Complementing its robust diagnostic services, the company also invests in research and development initiatives, continuously enhancing its test portfolio. This commitment to innovation ensures that they stay relevant in the ever-evolving healthcare landscape, capturing new opportunities and expanding their market reach. Through this strategic framework, Guangzhou Kingmed Diagnostics not only sustains its financial growth but also fortifies its leadership in the diagnostic services sector.

Intrinsic Value
26.41 CNY
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
209m CNY

Based on the financial report for Sep 30, 2025, Guangzhou Kingmed Diagnostics Group Co Ltd's Current Portion of Long-Term Debt amounts to 209m CNY.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
40%

Over the last year, the Current Portion of Long-Term Debt growth was 49%.

Back to Top